TY - JOUR
T1 - Animal models of hypertension
T2 - An overview
AU - Lerman, Lilach O.
AU - Chade, Alejandro R.
AU - Sica, Vincenzo
AU - Napoli, Claudio
N1 - Funding Information:
Supported in part by NIH Grants HL-63282 and 77131, the American Heart Association, and unrestricted research funds from “Regione Campania 2004–2005,” Naples, Italy.
PY - 2005/9
Y1 - 2005/9
N2 - Hypertension is a multifactorial disease involving complex interactions between genetic and environmental factors. Development of experimental models of hypertension allowed dissection and isolation of various factors associated with regulation of blood pressure, inheritance of hypertensive traits, and cellular responses to injury. The phenotype-driven approach is taking advantage of selective breeding of animals (primarily rats) that exhibit a desired phenotype, like the useful SHR. Genotype-driven models include transgenic techniques, in which mice are the most successful for selective deletion or overexpression of target genes. Notably, a combination of comparative genomics strategies and phenotypic correlates enhances the utility of hypertension models and their clinical relevance. Indeed, experimental models enabled development of targeted interventions aimed at decreasing not only blood pressure but also target organ injury. Continued utilization of experimental models simulating human hypertension, particularly those that combine other clinically relevant comorbidities like obesity or hypercholesterolemia, may afford development of effective strategies to address this common disease. Nevertheless, a cautious approach is mandatory when experimental findings in these models are extrapolated to human hypertension.
AB - Hypertension is a multifactorial disease involving complex interactions between genetic and environmental factors. Development of experimental models of hypertension allowed dissection and isolation of various factors associated with regulation of blood pressure, inheritance of hypertensive traits, and cellular responses to injury. The phenotype-driven approach is taking advantage of selective breeding of animals (primarily rats) that exhibit a desired phenotype, like the useful SHR. Genotype-driven models include transgenic techniques, in which mice are the most successful for selective deletion or overexpression of target genes. Notably, a combination of comparative genomics strategies and phenotypic correlates enhances the utility of hypertension models and their clinical relevance. Indeed, experimental models enabled development of targeted interventions aimed at decreasing not only blood pressure but also target organ injury. Continued utilization of experimental models simulating human hypertension, particularly those that combine other clinically relevant comorbidities like obesity or hypercholesterolemia, may afford development of effective strategies to address this common disease. Nevertheless, a cautious approach is mandatory when experimental findings in these models are extrapolated to human hypertension.
UR - http://www.scopus.com/inward/record.url?scp=23944435164&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=23944435164&partnerID=8YFLogxK
U2 - 10.1016/j.lab.2005.05.005
DO - 10.1016/j.lab.2005.05.005
M3 - Review article
C2 - 16131455
AN - SCOPUS:23944435164
SN - 1931-5244
VL - 146
SP - 160
EP - 173
JO - Translational Research
JF - Translational Research
IS - 3
ER -